Showing results (331-340 of 451) with videos related to

Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|July 18, 2013
Convenient synthesis of heterobifunctional poly(ethylene glycol) suitable for the functionalization of iron oxide nanoparticles for biomedical applicationsSolène Passemard, Davide Staedler, Lucia Učňová, et al.
Analytica Chimica Acta|March 27, 2016
Prediction of retention time in reversed-phase liquid chromatography as a tool for steroid identificationGiuseppe Marco Randazzo, David Tonoli, Stephanie Hambye, et al.
Frontiers in Molecular Biosciences|July 18, 2022
CK2β Is a Gatekeeper of Focal Adhesions Regulating Cell SpreadingOdile Filhol, Anne-Marie Hesse, Anne-Pascale Bouin, et al.
Diabetes & Metabolism|September 6, 2005
Diabetes: a major co-morbidity of cystic fibrosisM Costa, S Potvin, Y Berthiaume, et al.
Frontiers in Pharmacology|February 15, 2019
A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer TreatmentsMarie Paule Schneider, Leila Achtari Jeanneret, Bernard Chevaux, et al.
Journal of Medicinal Chemistry|October 1, 2015
Targeted γ-Secretase Inhibition To Control the Notch Pathway in Renal DiseasesLucienne Juillerat-Jeanneret, Alexander Flohr, Manfred Schneider, et al.
Bioorganic & Medicinal Chemistry|July 5, 2008
Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active siteHélène Fiaux, Douglas A Kuntz, Daniela Hoffman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 14, 2025
Efficient Fine-Tuning of Endothelial Gene Expression by a Single Tyrosine (Y685) to Phenylalanine Point Mutation in the VE-Cadherin GeneOlivia Garnier, Florian Jeanneret, Aude Durand, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 13, 2006
Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structuresFeride Cengelli, Dusica Maysinger, Florianne Tschudi-Monnet, et al.
Frontiers in Pharmacology|November 30, 2019
Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney InjuryJean-Christophe Wyss, Rajesh Kumar, Josip Mikulic, et al.
Pageof 46